1H-NMR metabolomics-based surrogates to impute common clinical risk factors and endpoints | 2022 Jan;75:103764 | EBioMedicine | doi: 10.1016/j.ebiom.2021.103764 Bizzarri D, Reinders MJT, Beekman M, Slagboom PE, BBMRI-NL, van den Akker EB. Abstract Background: Missing or incomplete phenotypic information can severely deteriorate the statistical power in epidemiological studies. High-throughput quantification of small-molecules in bio-samples, i.e. 'metabolomics', [...]